Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Y. Eberhard
Selective Inhibition of Histone Deacetylases Sensitizes Malignant Cells to Death Receptor Ligands
Molecular Cancer Therapeutics
Cancer Research
Oncology
Related publications
Innovative Strategies for Selective Inhibition of Histone Deacetylases
Cell Chemical Biology
Molecular Medicine
Molecular Biology
Pharmacology
Biochemistry
Clinical Biochemistry
Drug Discovery
Phosphatidylinositol 3-Kinase Inhibition Broadly Sensitizes Glioblastoma Cells to Death Receptor- And Drug-Induced Apoptosis
Cancer Research
Cancer Research
Oncology
Rapamycin Sensitizes Akt Inhibition in Malignant Human Breast Epithelial Cells
Cancer Letters
Cancer Research
Oncology
Brca2Deficiency Sensitizes Cells to PARP Inhibition
Cancer Research
Cancer Research
Oncology
Inhibition of Histone Deacetylases in Cancer Therapy: Lessons From Leukaemia
British Journal of Cancer
Cancer Research
Oncology
Triptolide Sensitizes Pancreatic Cancer Cells to TRAIL-induced Activation of the Death Receptor Pathway
Cancer Letters
Cancer Research
Oncology
The Antidiabetic Agent LG100754 Sensitizes Cells to Low Concentrations of Peroxisome Proliferator-Activated Receptor Γ Ligands
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Adenosine Mimetics as Inhibitors of NAD+-Dependent Histone Deacetylases, From Kinase to Sirtuin Inhibition
Targeting HSF1 Sensitizes Cancer Cells to HSP90 Inhibition
Oncotarget
Oncology
